Translation control of TAK1 mRNA by hnRNP K modulates LPS-induced macrophage activation

RNA

Volumn 20, Issue 6, 2014, Pages 899-911

  Liepelt, Anke ^a   Mossanen, Jana C ^a   Denecke, Bernd ^a   Heymann, Felix ^a   Santis, Rebecca De ^a   Tacke, Frank ^a   Marx, Gernot ^a   Ostareck, Dirk H ^a   Ostareck Lederer, Antje ^a  

^a UNIVERSITY HOSPITAL RWTH AACHEN   (Germany)

Author keywords

HnRNP K; LPS; Post transcriptional regulation; TAK1 mRNA; TLR4 signaling

Indexed keywords

BACTERIUM LIPOPOLYSACCHARIDE; HETEROGENEOUS NUCLEAR RIBONUCLEOPROTEIN K; INTERCELLULAR ADHESION MOLECULE 2; INTERLEUKIN 1 RECEPTOR ASSOCIATED KINASE 1; INTERLEUKIN 1 RECEPTOR ASSOCIATED KINASE 4; INTERLEUKIN 10; INTERLEUKIN 1BETA; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE P38; RNA 18S; RNA 28S; TOLL LIKE RECEPTOR 4; TRANSFORMING GROWTH FACTOR BETA ACTIVATED KINASE 1; TUMOR NECROSIS FACTOR RECEPTOR ASSOCIATED FACTOR 6;

3' UNTRANSLATED REGION; ANIMAL CELL; ARTICLE; CONTROLLED STUDY; CYTOKINE RESPONSE; GENE SILENCING; HEMATOPOIETIC CELL; IMMUNOPRECIPITATION; INFLAMMATION; INNATE IMMUNITY; L929 CELL LINE; MACROPHAGE ACTIVATION; MESSENGER RNA SYNTHESIS; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA BINDING; RNA PROCESSING; RNA STABILITY; RNA TRANSLATION; SIGNAL TRANSDUCTION; TRANSLATION REGULATION;

HNRNP K; LPS; POST-TRANSCRIPTIONAL REGULATION; TAK1 MRNA; TLR4-SIGNALING;

3' UNTRANSLATED REGIONS; ANIMALS; CELL LINE; GENE EXPRESSION REGULATION; HETEROGENEOUS-NUCLEAR RIBONUCLEOPROTEIN K; INFLAMMATION; INTERLEUKIN-10; INTERLEUKIN-1BETA; LIPOPOLYSACCHARIDES; MACROPHAGE ACTIVATION; MACROPHAGES; MAP KINASE KINASE KINASES; MICE; PROTEIN BIOSYNTHESIS; RNA PROCESSING, POST-TRANSCRIPTIONAL; RNA, MESSENGER; SIGNAL TRANSDUCTION; TOLL-LIKE RECEPTOR 4; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84901450105     PISSN: 13558382     EISSN: 14699001     Source Type: Journal    
DOI: 10.1261/rna.042788.113     Document Type: Article

References (62)

1. Adolph D, Flach N, Mueller K, Ostareck DH, Ostareck-Lederer A. 2007.Deciphering the cross talk between hnRNP K and c-Src: The c-Srcactivation domain in hnRNP K is distinct from a second interactionsite. Mol Cell Biol 27: 1758-1770.
2. Anderson P. 2008. Post-transcriptional control of cytokine production.Nat Immunol 9: 353-359.
3. Barton DJ, Flanegan JB. 1993. Coupled translation and replication ofpoliovirus RNA in vitro: synthesis of functional 3D polymeraseand infectious virus. J Virol 67: 822-831. (Pubitemid 23032061)
4. Cantley LC. 2002. The phosphoinositide 3-kinase pathway. Science 296:1655-1657. (Pubitemid 34579158)
5. Ceci M, Gaviraghi C, Gorrini C, Sala LA, Offenhauser N, Marchisio PC,Biffo S. 2003. Release of eIF6 (p27BBP) from the 60S subunit allows80S ribosome assembly. Nature 426: 579-584. (Pubitemid 37522646)
6. Ceppi M, Pereira PM, Dunand-Sauthier I, Barras E, Reith W,Santos MA, Pierre P. 2009. MicroRNA-155 modulates the interleukin-1 signaling pathway in activated human monocyte-derived dendriticcells. Proc Natl Acad Sci 106: 2735-2740.
7. Clark A, Dean J, Tudor C, Saklatvala J. 2009. Post-transcriptional generegulation by MAP kinases via AU-rich elements. Front Biosci 14:847-871.
8. Conner JR, Smirnova II, Moseman AP, Poltorak A. 2010. IRAK1BP1 inhibitsinflammation by promoting nuclear translocation of NF-κBp50. Proc Natl Acad Sci 107: 11477-11482.
9. Covic M, Hassa PO, Saccani S, Buerki C, Meier NI, Lombardi C,Imhof R, Bedford MT, Natoli G, Hottiger MO. 2005. Argininemethyltransferase CARM1 is a promoter-specific regulator of NF-κB-dependent gene expression. EMBO J 24: 85-96. (Pubitemid 40188466)
10. D'Anto V, Eckhardt A, Hiller KA, Spagnuolo G, Valletta R, Ambrosio L,Schmalz G, Schweikl H. 2009. The influence of Ni(II) on surfaceantigen expression in murine macrophages. Biomaterials 30: 1492-1501.
11. de Vries S, Naarmann-de Vries IS, Urlaub H, Lue H, Bernhagen J,Ostareck DH, Ostareck-Lederer A. 2013. Identification of DEADboxRNA helicase 6 (DDX6) as a cellular modulator of vascular endothelialgrowth factor expression under hypoxia. J Biol Chem 288:5815-5827.
12. DeMaria CT, Brewer G. 1996. AUF1 binding affinity to A+U-rich elementscorrelates with rapid mRNA degradation. J Biol Chem 271:12179-12184. (Pubitemid 26160876)
13. DeMaria CT, Sun Y, Long L, Wagner BJ, Brewer G. 1997. Structural determinantsin AUF1 required for high affinity binding to A + U-richelements. J Biol Chem 272: 27635-27643. (Pubitemid 27473557)
14. Ducut Sigala JL, Bottero V, Young DB, Shevchenko A, Mercurio F,Verma IM. 2004. Activation of transcription factor NF-κB requiresELKS, an IκB kinase regulatory subunit. Science 304: 1963-1967. (Pubitemid 38822188)
15. Gan L, Li L. 2006. Regulations and roles of the interleukin-1 receptorassociated kinases (IRAKs) in innate and adaptive immunity.Immunol Res 35: 295-302. (Pubitemid 46020729)
16. Gruber AR, Fallmann J, Kratochvill F, Kovarik P, Hofacker IL.2010. AREsite: a database for the comprehensive investigationof AU-rich elements. Nucleic Acids Res 39(Database issue):D66-D69.
17. Grullich C, Duvoisin RM, Wiedmann M, van Leyen K. 2001. Inhibitionof 15-lipoxygenase leads to delayed organelle degradation in the reticulocyte.FEBS Lett 489: 51-54.
18. Guha M, Mackman N. 2001. LPS induction of gene expression in humanmonocytes. Cell Signal 13: 85-94. (Pubitemid 32222977)
19. Guha M, Mackman N. 2002. The phosphatidylinositol 3-kinase-Aktpathway limits lipopolysaccharide activation of signaling pathwaysand expression of inflammatory mediators in human monocyticcells. J Biol Chem 277: 32124-32132. (Pubitemid 34969025)
20. Hitti E, Iakovleva T, Brook M, Deppenmeier S, Gruber AD, Radzioch D,Clark AR, Blackshear PJ, Kotlyarov A, Gaestel M. 2006. Mitogen-activatedprotein kinase-activated protein kinase 2 regulates tumor necrosisfactor mRNA stability and translation mainly by alteringtristetraprolin expression, stability, and binding to adenine/uridine-rich element. Mol Cell Biol 26: 2399-2407. (Pubitemid 43346938)
21. Honda K, Taniguchi T. 2006. IRFs: master regulators of signalling byToll-like receptors and cytosolic pattern-recognition receptors. NatRev Immunol 6: 644-658. (Pubitemid 44298214)
22. Iizuka N, Najita L, Franzusoff A, Sarnow P. 1994. Cap-dependent andcap-independent translation by internal initiation of mRNAs incell extracts prepared from Saccharomyces cerevisiae. Mol Cell Biol14: 7322-7330. (Pubitemid 24326397)
23. Inoue J, Gohda J, Akiyama T. 2007. Characteristics and biological functionsof TRAF6. Adv Exp Med Biol 597: 72-79.
24. Janssens S, Beyaert R. 2002. A universal role for MyD88 in TLR/IL-1Rmediatedsignaling. Trends Biochem Sci 27: 474-482.
25. Kim TW, Staschke K, Bulek K, Yao J, Peters K, Oh KH, Vandenburg Y,Xiao H, Qian W, Hamilton T, et al. 2007. A critical role for IRAK4kinase activity in Toll-like receptor-mediated innate immunity. J ExpMed 204: 1025-1036. (Pubitemid 46798147)
26. Kratochvill F, Machacek C, Vogl C, Ebner F, Sedlyarov V, Gruber AR,Hartweger H, Vielnascher R, Karaghiosoff M, Rulicke T, et al.2011. Tristetraprolin-driven regulatory circuit controls quality andtiming of mRNA decay in inflammation. Mol Syst Biol 7: 560.
27. Lee JS, NauseefWM,Moeenrezakhanlou A, Sly LM, Noubir S, Leidal KG,Schlomann JM, Krystal G, Reiner NE. 2007. Monocyte p110α phosphatidylinositol3-kinase regulates phagocytosis, the phagocyte oxidase,and cytokine production. J Leukoc Biol 81: 1548-1561. (Pubitemid 46827977)
28. Livak KJ, Schmittgen TD. 2001. Analysis of relative gene expression datausing real-time quantitative PCR and the 2-δ δ CT method. Methods25: 402-408. (Pubitemid 34164012)
29. Messias AC, Harnisch C, Ostareck-Lederer A, Sattler M, Ostareck DH.2006. The DICE-binding activity of KH domain 3 of hnRNP K is affectedby c-Src-mediated tyrosine phosphorylation. J Mol Biol 361:470-481. (Pubitemid 44118333)
30. Miyake K. 2006. Roles for accessory molecules in microbial recognitionby Toll-like receptors. J Endotoxin Res 12: 195-204. (Pubitemid 47470163)
31. Naarmann IS, Harnisch C, Flach N, Kremmer E, Kuhn H, Ostareck DH,Ostareck-Lederer A. 2008. mRNA silencing in human erythroidcell maturation: heterogeneous nuclear ribonucleoprotein K controlsthe expression of its regulator c-Src. J Biol Chem 283: 18461-18472.
32. Naarmann IS, Harnisch C, Muller-Newen G, Urlaub H, Ostareck-Lederer A, Ostareck DH. 2010. DDX6 recruits translational silencedhuman reticulocyte 15-lipoxygenase mRNA to RNP granules. RNA16: 2189-2204.
33. Naarmann-de Vries IS, Urlaub H, Ostareck DH, Ostareck-Lederer A.2013. Caspase-3 cleaves hnRNP K in erythroid differentiation. CellDeath Dis 4: e548.
34. O'Neill LA. 2006. How Toll-like receptors signal: what we know andwhat we don't know. Curr Opin Immunol 18: 3-9. (Pubitemid 43049641)
35. Ostareck DH, Ostareck-Lederer A, Wilm M, Thiele BJ, Mann M,Hentze MW. 1997. mRNA silencing in erythroid differentiation:hnRNP K and hnRNP E1 regulate 15-lipoxygenase translationfrom the 3′ end. Cell 89: 597-606. (Pubitemid 27511770)
36. Ostareck DH, Ostareck-Lederer A, Shatsky IN, Hentze MW. 2001.Lipoxygenase mRNA silencing in erythroid differentiation: the3′UTR regulatory complex controls 60S ribosomal subunit joining.Cell 104: 281-290.
37. Ostareck-Lederer A, Ostareck DH. 2012. Precision mechanics with multifunctionaltools: how hnRNP K and hnRNPs E1/E2 contribute topost-transcriptional control of gene expression in hematopoiesis.Curr Protein Pept Sci 13: 391-400.
38. Ostareck-Lederer A, Ostareck DH, Standart N, Thiele BJ. 1994.Translation of 15-lipoxygenase mRNA is inhibited by a proteinthat binds to a repeated sequence in the 3′ untranslated region.EMBO J 13: 1476-1481.
39. Ostareck-Lederer A, Ostareck DH, Cans C, Neubauer G, Bomsztyk K,Superti-Furga G, Hentze MW. 2002. c-Src-mediated phosphorylationof hnRNP K drives translational activation of specifically silencedmRNAs. Mol Cell Biol 22: 4535-4543. (Pubitemid 34620391)
40. Park BS, Song DH, Kim HM, Choi BS, Lee H, Lee JO. 2009. The structuralbasis of lipopolysaccharide recognition by the TLR4-MD-2complex. Nature 458: 1191-1195.
41. Rapoport SM, Schewe T. 1986. The maturational breakdown of mitochondriain reticulocytes. Biochim Biophys Acta 864: 471-495.
42. Reynier F, de Vos AF, Hoogerwerf JJ, Bresser P, van der Zee JS, Paye M,Pachot A, Mougin B, van der Poll T. 2012. Gene expression profilesin alveolar macrophages induced by lipopolysaccharide in humans.Mol Med 18: 1303-1311.
43. Rutledge HR, Jiang W, Yang J, Warg LA, Schwartz DA, Pisetsky DS,Yang IV. 2011. Gene expression profiles of RAW264.7 macrophagesstimulated with preparations of LPS differing in isolation and purity.Innate Immun 18: 80-88.
44. Sakurai H. 2012. Targeting of TAK1 in inflammatory disorders and cancer.Trends Pharmacol Sci 33: 522-530.
45. Sarkar S, Han J, Sinsimer KS, Liao B, Foster RL, Brewer G, Pestka S.2011. RNA-binding protein AUF1 regulates lipopolysaccharide-inducedIL10 expression by activating IκB kinase complex in monocytes.Mol Cell Biol 31: 602-615.
46. Shanmugam N, Reddy MA, Natarajan R. 2008. Distinct roles of heterogeneousnuclear ribonuclear protein K and microRNA-16 in cyclooxygenase-2 RNA stability induced by S100b, a ligand of thereceptor for advanced glycation end products. J Biol Chem 283:36221-36233.
47. Shimazu R, Akashi S, Ogata H, Nagai Y, Fukudome K, Miyake K,Kimoto M. 1999. MD-2, a molecule that confers lipopolysaccharideresponsiveness on Toll-like receptor 4. J Exp Med 189: 1777-1782. (Pubitemid 29272694)
48. Stoecklin G, Tenenbaum SA, Mayo T, Chittur SV, George AD,Baroni TE, Blackshear PJ, Anderson P. 2008. Genome-wide analysisidentifies interleukin-10 mRNA as target of tristetraprolin. J BiolChem 283: 11689-11699.
49. Tacke F, Randolph GJ. 2006. Migratory fate and differentiation of bloodmonocyte subsets. Immunobiology 211: 609-618.
50. Taganov KD, Boldin MP, Chang KJ, Baltimore D. 2006. NF-κB- dependentinduction of microRNA miR-146, an inhibitor targeted to signalingproteins of innate immune responses. Proc Natl Acad Sci 103:12481-12486. (Pubitemid 44267285)
51. Thisted T, Lyakhov DL, Liebhaber SA. 2001. Optimized RNA targets oftwo closely related triple KH domain proteins, heterogeneous nuclearribonucleoprotein K and αCP-2KL, suggest distinct modes ofRNA recognition. J Biol Chem 276: 17484-17496.
52. Thomas PD, Campbell MJ, Kejariwal A, Mi H, Karlak B, Daverman R,Diemer K, Muruganujan A, Narechania A. 2003. PANTHER: a libraryof protein families and subfamilies indexed by function.Genome Res 13: 2129-2141.
53. Tiedje C, Kotlyarov A, Gaestel M. 2010. Molecular mechanisms of phosphorylation-regulated TTP (tristetraprolin) action and screening forfurther TTP-interacting proteins. Biochem Soc Trans 38: 1632-1637.
54. Tiedje C, Ronkina N, Tehrani M, Dhamija S, Laass K, Holtmann H,Kotlyarov A, Gaestel M. 2012. The p38/MK2-driven exchange betweentristetraprolin and HuR regulates AU-rich element-dependenttranslation. PLoS Genet 8: e1002977.
55. Ulloa L, Tracey KJ. 2005. The "cytokine profile": a code for sepsis.Trends Mol Med 11: 56-63.
56. van Leyen K, Duvoisin RM, Engelhardt H, Wiedmann M. 1998. A functionfor lipoxygenase in programmed organelle degradation. Nature395: 392-395. (Pubitemid 28450690)
57. Wagner BJ, DeMaria CT, Sun Y, Wilson GM, Brewer G. 1998. Structureand genomic organization of the human AUF1 gene: alternative premRNAsplicing generates four protein isoforms. Genomics 48:195-202. (Pubitemid 28164499)
58. Wang C, Deng L, Hong M, Akkaraju GR, Inoue J, Chen ZJ. 2001. TAK1is a ubiquitin-dependent kinase of MKK and IKK. Nature 412: 346-351. (Pubitemid 32694385)
59. Weischenfeldt J, Porse B. 2008. Bone marrow-derived macrophages(BMM): isolation and applications. CSH Protoc 2008: pdb prot5080.
60. Wilusz CJ, Wormington M, Peltz SW. 2001. The cap-to-tail guide tomRNA turnover. Nat Rev Mol Cell Biol 2: 237-246.
61. Winzen R, Thakur BK, Dittrich-Breiholz O, Shah M, Redich N,Dhamija S, Kracht M, Holtmann H. 2007. Functional analysis ofKSRP interaction with the AU-rich element of interleukin-8 andidentification of inflammatory mRNA targets. Mol Cell Biol 27:8388-8400. (Pubitemid 350234249)
62. Yamamoto M, Sato S, Hemmi H, Hoshino K, Kaisho T, Sanjo H,Takeuchi O, Sugiyama M, Okabe M, Takeda K, et al. 2003. Role ofadaptor TRIF in the MyD88-independent toll-like receptor signalingpathway. Science 301: 640-643. (Pubitemid 36927946)